HMG-CoA Reductase Inhibitor [EPC]

316490 reported adverse events

Drugs of this class: SIMVASTATIN LOVASTATIN EZETIMIBE AND SIMVASTATIN ATORVASTATIN CALCIUM PITAVASTATIN MAGNESIUM ROSUVASTATIN

These side effects are most commonly reported by patients taking drugs of the HMG-CoA Reductase Inhibitor [EPC] class:

# Side effect Count
0 FATIGUE 16676
1 NAUSEA 15844
2 DRUG INEFFECTIVE 15673
3 DYSPNOEA 15202
4 DIARRHOEA 14044
5 DIZZINESS 13420
6 ASTHENIA 11421
7 PAIN 11164
8 FALL 10920
9 MYALGIA 10700
See all common reactions for HMG-CoA Reductase Inhibitor [EPC]

Drugs of the HMG-CoA Reductase Inhibitor [EPC] class are most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 IMMUNE-MEDIATED NECROTISING MYOPATHY 256 0.4621
1 IMMUNE-MEDIATED MYOSITIS 251 0.3984
2 MYOPATHY 1635 0.2588
3 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 221 0.2570
4 HYPERPARATHYROIDISM SECONDARY 514 0.2468
5 NEPHROGENIC ANAEMIA 914 0.2294
6 RHABDOMYOLYSIS 6901 0.2246
7 REBOUND ACID HYPERSECRETION 482 0.1687
8 POLYMYOSITIS 204 0.1518
9 MYOSITIS 868 0.1489
See all enriched reactions for HMG-CoA Reductase Inhibitor [EPC]